Beam Therapeutics Inc (BEAM) stock news · rev $139.7M
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
This BEAM news page leads with what Beam Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for BEAM yet. We will not pad this page with generic market recap.
Latest reported BEAM revenue for 2025-12-31 was $139.7M. Net income was -$80.0M. Revenue was up 120.0% from 2024-12-31 to 2025-12-31. BEAM currently screens at market cap $2.01B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BEAM stock page; for the tape open the quote page.
BEAM stock news FAQ
What are BEAM's latest revenue and net income?
Latest cached Beam Therapeutics Inc (BEAM) revenue for Dec 31, 2025 was $139.7M. Net income was -$80.0M. Statements: https://lician.com/financials/beam
How did BEAM revenue change from the prior cached period?
Cached Beam Therapeutics Inc (BEAM) revenue was up 120.0% from $63.5M (Dec 31, 2024) to $139.7M (Dec 31, 2025). Statements: https://lician.com/financials/beam
What is BEAM's market cap?
Beam Therapeutics Inc (BEAM) market cap is $2.01B on the latest cached fundamentals snapshot.
What kind of company is BEAM?
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Where is BEAM stock news listed?
Cached stock news for Beam Therapeutics Inc (BEAM) is listed at https://lician.com/news/beam. Filings: https://lician.com/sec/beam
Not investment advice.